SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-081262
Filing Date
2023-10-10
Accepted
2023-10-10 06:15:31
Documents
11
Period of Report
2023-10-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea186534-6k_incannex.htm 6-K 12822
2 ASX ANNOUNCEMENT, DATED OCTOBER 10, 2023 SCHEME BOOKLET DISPATCHED ea186534ex99-1_incannex.htm EX-99.1 52125
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3710
4 GRAPHIC ex99-1_002.jpg GRAPHIC 6858
5 GRAPHIC ex99-1_003.jpg GRAPHIC 9049
6 GRAPHIC ex99-1_004.jpg GRAPHIC 559712
7 GRAPHIC ex99-1_005.jpg GRAPHIC 432493
8 GRAPHIC ex99-1_006.jpg GRAPHIC 687803
9 GRAPHIC ex99-1_007.jpg GRAPHIC 509896
10 GRAPHIC ex99-1_008.jpg GRAPHIC 561542
11 GRAPHIC ex99-1_009.jpg GRAPHIC 428970
  Complete submission text file 0001213900-23-081262.txt   4473161
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Ltd (Filer) CIK: 0001873875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-41106 | Film No.: 231315504
SIC: 2834 Pharmaceutical Preparations